Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Netherlands

Marie Skłodowska-Curie Action · Running

InnoCAR-T Innovative design and implementation of next-generation Point-of-Care CAR-T

Coordinator
Academisch Ziekenhuis Groningen, Netherlands
Runs
1 January 2023 to 31 December 2026
Status
Running
EU funding
€2.6m
Total cost
—
Partners
10 organisations in 4 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101072861

What the project is doing

In the project's own words, from its summary on CORDIS.

InnoCAR-T is a Doctoral Network designed to provide training and carry out breakthrough research on the high impact field of Chimeric Antigen Receptor (CAR) T cell immunotherapy in a carefully integrated academic and inter-sectoral programme. We aim to develop next-generation CAR-T therapy and deliver a set of young researchers uniquely qualified for a career in academia and/or industry. CAR-T cell therapy represents a revolutionary advance in oncology, particularly for B cell lymphoma patients.

However, long-term response is still restricted to ~50% of patients, with resistance being even more prominent in other cancers. Thus, additional innovations to overcome resistance are needed to improve CAR-T responses. Unfortunately, the currently centralized production of CAR-T hampers rapid innovation and associates with prohibitive costs, long vein-to-vein time, and poor carbon footprint due to inter-continental delivery.

InnoCAR-T aims touse innovative academic and industrial concepts to address these issues by 1. developing innovative manufacturing solutions for CAR-T production at local academic hospitals and 2. developing the next-generation of more effective CAR-Ts. At the core of InnoCAR-T is its training objective to offer a cutting-edge multidisciplinary training programme. Herewith, outstanding young scientists can generate breakthrough ideas and assume leading positions in academia and industry.

The training programme includes an array of disciplines, ranging from biomedical sciences (e.g. immunology, CAR engineering, gene-editing), physical sciences to mechanical engineering. Industrial partners are central to the programme and provide pivotal expertise on how to translate scientific discoveries into commercial reality. Inter-sectoral partners will host Doctoral Candidates, provide key secondments and network-wide training events.

Further, InnoCAR-T will foster long-term multi-disciplinary research and bilateral co-operations between academia and industry.

Topics

Who is involved

OrganisationCityCountryRole
Academisch Ziekenhuis GroningenGroningenNetherlandsCoordinator
Universiteit GentGentBelgiumParticipant
Eurice European Research and Project Office GmbHSt IngbertGermanyAssociatedpartner
Fundacio De Recerca Clinic Barcelona-Institut D Investigacions Biomediques August Pi I SunyerBarcelonaSpainParticipant
Integra Therapeutics S.l.BarcelonaSpainParticipant
Universidad Pompeu FabraBarcelonaSpainAssociatedpartner
Universitat De BarcelonaBarcelonaSpainAssociatedpartner
European Hematology AssociationDen HaagNetherlandsAssociatedpartner
Learning By SimulationBerlicumNetherlandsAssociatedpartner
Scinus Cell Expansion Netherlands B.v.ZeistNetherlandsParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI